Plain-English translation of NCT06736171 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether robotic exoskeletons—wearable devices that help support and guide your legs—can help stroke survivors recover better walking ability. You would receive either training with one of three robotic exoskeletons (AtalanteX, Ekso NR, or Restore) or standard physical therapy sessions. The study will measure how well each approach works by looking at walking ability, strength, and quality of life.
After a stroke, many people have difficulty walking on one side of their body. Researchers want to find out whether robotic exoskeletons—which are becoming more available—can help people recover walking ability better than traditional therapy alone.
You likely qualify if…
You likely don't qualify if…
You would attend sessions 2 to 3 times per week for 3 to 4 weeks, for a total of 9 training sessions led by a licensed physical therapist. If you are assigned to the robotic exoskeleton group, you would wear one of the devices during gait training to help support and guide your walking. If you are in the standard care group, you would receive traditional physical therapy. Throughout the study, the team will measure your walking ability and ask about your quality of life.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States
Sponsor
Kessler Foundation
Enrollment target
~96 participants
Started
May 2025
Primary completion
December 2029
Age range
50 Years – 80 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sharon Franco
Kessler Foundation
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.